Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression.
Vallacchi V, Vergani E, Camisaschi C, Deho P, Cabras AD, Sensi M, De Cecco L, Bassani N, Ambrogi F, Carbone A, Crippa F, Vergani B, Frati P, Arienti F, Patuzzo R, Villa A, Biganzoli E, Canevari S, Santinami M, Castelli C, Rivoltini L, Rodolfo M. Vallacchi V, et al. Among authors: rivoltini l. Cancer Res. 2014 Jan 1;74(1):130-40. doi: 10.1158/0008-5472.CAN-13-1672. Cancer Res. 2014. PMID: 24395820
Treatment of recurrent in transit metastases from cutaneous melanoma by isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine activated killer cells. A pilot study.
Belli F, Arienti F, Rivoltini L, Santinami M, Mascheroni L, Prada A, Ammatuna M, Marchesi E, Parmiani G, Cascinelli N, et al. Belli F, et al. Among authors: rivoltini l. Melanoma Res. 1992 Nov;2(4):263-71. doi: 10.1097/00008390-199211000-00007. Melanoma Res. 1992. PMID: 1490114
Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules.
Arienti F, Gambacorti-Passerini C, Borin L, Rivoltini L, Orazi A, Pogliani EM, Corneo G, Parmiani G. Arienti F, et al. Among authors: rivoltini l. Ann Oncol. 1992 Feb;3(2):155-62. doi: 10.1093/oxfordjournals.annonc.a058133. Ann Oncol. 1992. PMID: 1606087 Free article.
Differences between in vivo and in vitro activation of cancer patient lymphocytes by recombinant interleukin 2: possible role for lymphokine-activated killer cell infusion in the in vivo-induced activation.
Gambacorti-Passerini C, Rivoltini L, Radrizzani M, Belli F, Sciorelli G, Ravagnani F, Galazka AR, Cascinelli N, Parmiani G. Gambacorti-Passerini C, et al. Among authors: rivoltini l. Cancer Res. 1989 Sep 15;49(18):5230-4. Cancer Res. 1989. PMID: 2788498
240 results